-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Tarsus Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q3 2019 to Q2 2024.
- Tarsus Pharmaceuticals, Inc. Depreciation for the quarter ending June 30, 2024 was $100K, a 50% decline year-over-year.
- Tarsus Pharmaceuticals, Inc. Depreciation for the twelve months ending June 30, 2024 was $710K, a 65.5% increase year-over-year.
- Tarsus Pharmaceuticals, Inc. annual Depreciation for 2023 was $744K, a 129% increase from 2022.
- Tarsus Pharmaceuticals, Inc. annual Depreciation for 2022 was $325K, a 8.33% increase from 2021.
- Tarsus Pharmaceuticals, Inc. annual Depreciation for 2021 was $300K, a 200% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)